Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.08 USD | +2.41% | +2.91% | -18.79% |
02:58pm | Bristol Myers: presents advances in lung cancer | CF |
06-02 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.79% | 83.29B | |
+42.64% | 739B | |
+32.82% | 598B | |
-5.63% | 353B | |
+17.19% | 318B | |
+3.88% | 285B | |
+16.51% | 240B | |
+9.78% | 210B | |
-5.19% | 206B | |
+7.11% | 164B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab